Mahesh Akram 13D/13G Filings for Amneal Pharmaceuticals, Inc. (AMRX)

Mahesh Akram 13D and 13G filings for Amneal Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
4:11 pm
Sale
2024-09-30 13G Amneal Pharmaceuticals, Inc.
AMRX
Mahesh Akram 26,856,413
8.800%
-3,528,356decrease
(-11.61%)
Filing
2024-01-05
4:09 pm
Purchase
2024-01-01 13G Amneal Pharmaceuticals, Inc.
AMRX
Mahesh Akram 30,384,769
9.900%
30,384,769increase
(New Position)
Filing